Legal & General Group PLC Karyopharm Therapeutics Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.14 - $1.81 $90,680 - $143,974	-79,544 Reduced 85.28%	13,735 $18,000
Q2 2023 Aug 14, 2023	BUY	$1.79 - $4.59 $80,134 - $205,485	44,768 Added 92.28%	93,279 $166,000
Q1 2023 May 15, 2023	BUY	$2.84 - $3.92 $7,645 - $10,552	2,692 Added 5.88%	48,511 $188,000
Q4 2022 Feb 14, 2023	BUY	$2.48 - $5.93 $19,840 - $47,440	8,000 Added 21.15%	45,819 $155,000
Q3 2022 Nov 14, 2022	BUY	$4.08 - $5.82 $17,315 - $24,700	4,244 Added 12.64%	37,819 $207,000
Q2 2022 Aug 22, 2022	BUY	$4.15 - $8.37 $7,179 - $14,480	1,730 Added 5.43%	33,575 $151,000
Q4 2021 Feb 14, 2022	BUY	$5.21 - $8.61 $9,357 - $15,463	1,796 Added 5.98%	31,845 $205,000
Q3 2021 Nov 15, 2021	BUY	$4.45 - $10.63 $52,131 - $124,530	11,715 Added 63.9%	30,049 $175,000
Q2 2021 Aug 12, 2021	SELL	$8.11 - $11.11 $6,723 - $9,210	-829 Reduced 4.33%	18,334 $190,000
Q1 2021 May 17, 2021	BUY	$9.85 - $17.69 $1,674 - $3,007	170 Added 0.9%	19,163 $202,000
Q4 2020 Feb 12, 2021	SELL	$14.15 - $17.19 $1,669 - $2,028	-118 Reduced 0.62%	18,993 $294,000
Q3 2020 Nov 13, 2020	SELL	$14.14 - $19.71 $43,551 - $60,706	-3,080 Reduced 13.88%	19,111 $279,000
Q2 2020 Aug 14, 2020	BUY	$16.6 - $25.25 $148,935 - $226,543	8,972 Added 67.87%	22,191 $420,000
Q1 2020 May 14, 2020	SELL	$14.38 - $27.72 $40,120 - $77,338	-2,790 Reduced 17.43%	13,219 $254,000
Q4 2019 Feb 13, 2020	BUY	$9.23 - $19.67 $25,327 - $53,974	2,744 Added 20.69%	16,009 $306,000
Q3 2019 Nov 13, 2019	BUY	$5.66 - $11.85 $7,986 - $16,720	1,411 Added 11.9%	13,265 $128,000
Q2 2019 Aug 14, 2019	BUY	$4.32 - $6.43 $7,508 - $11,175	1,738 Added 17.18%	11,854 $71,000
Q4 2018 Feb 15, 2019	BUY	$8.2 - $16.95 $19,770 - $40,866	2,411 Added 31.29%	10,116 $95,000
Q2 2018 Aug 10, 2018	BUY	$12.0 - $19.88 $15,504 - $25,684	1,292 Added 20.15%	7,705 $131,000
Q1 2018 May 17, 2018	SELL	$9.92 - $17.25 $28,817 - $50,111	-2,905 Reduced 31.18%	6,413 $86,000
Q4 2017 Feb 13, 2018	BUY	$9.15 - $11.99 $85,259 - $111,722	9,318	9,318 $90,000

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

Vanguard Group Inc Valley Forge, PA

7.65M
Shares

$4.9 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

5.55M
Shares

$3.55 Million
0.36% of portfolio
Palo Alto Investors LP Palo Alto, CA

5.1M
Shares

$3.27 Million
0.58% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.32M
Shares

$2.76 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.17M
Shares

$2.67 Million
0.0% of portfolio

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $51.1M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account